| OTC Markets: PSID
PositiveID Corp. develops molecular diagnostic systems for bio-threat detection and rapid medical testing. The company, through its subsidiary, MicroFluidic Systems, develops fully automated pathogen detection systems and assays to detect a range of biological threats. It focuses on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment. PositiveID was founded in November 2001 and is headquartered in Delray Beach, FL.